Novel observational study protocol to develop a prediction model that identifies patients with Graves’ ophthalmopathy insensitive to intravenous glucocorticoids pulse therapy

INTRODUCTION: Intravenous glucocorticoids pulse therapy is the first-line treatment for moderate-to-severe and active Graves’ ophthalmopathy, with a large proportion of patients having poor efficacy and exposed to the risk of glucocorticoids adverse effects. We introduce a novel protocol to develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi, Wang, Hui, Li, Lunhao, Li, Yinwei, Sun, Jing, Song, Xuefei, Zhou, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679131/
https://www.ncbi.nlm.nih.gov/pubmed/34916318
http://dx.doi.org/10.1136/bmjopen-2021-053173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679131/
https://www.ncbi.nlm.nih.gov/pubmed/34916318
http://dx.doi.org/10.1136/bmjopen-2021-053173

Ejemplares similares